On June 6, 2019 Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage biotechnology company focused on the development of novel cancer therapeutics, reported Susan M. Molineaux, Ph.D, founder, CEO and President and Keith Orford, M.D., Ph.D., Senior Vice President of Clinical Development will participate in the following two investment conferences in June (Press release, Calithera Biosciences, JUN 6, 2018, View Source [SID1234535238]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Jefferies 2018 Healthcare Conference at the Grand Hyatt in New York City. Calithera will present at the conference today, June 6, 2018 at 8:00 a.m. Eastern time. A live webcast of this presentation will be accessible via the media and investors page of www.calithera.com. An archived replay of the webcast will be available on the Company’s website for 30 days following the conference.

The JMP Securities 2018 Life Sciences Conference at the St.Regis in New York City. Calithera will participate in a panel discussion on June 20, 2018 at 3:30 p.m. Eastern time.